Table 2.
Analysis | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
Covariate | HR | 95% CI | p value | HR | 95% CI | p value | |
Age | ≥ 70 years | 0.8 | 0.7–1.0 | 0.060 | |||
AFP | > 400 ng/mL | 1.0 | 0.8–1.2 | 0.940 | |||
Albumin | < 35 g/L | 2.0 | 1.7–2.4 | < 0.001 | 1.9 | 1.5–2.3 | < 0.001 |
Bilirubin | ≥ 1.2 mg/dL | 1.8 | 1.5–2.1 | < 0.001 | 1.6 | 1.3–2.0 | < 0.001 |
AST level | > 31 U/L | 1.5 | 1.1–2.0 | 0.011 | 1.3 | 0.9–1.9 | 0.148 |
ALT level | ≥ 35 U/L | 1.1 | 0.9–1.3 | 0.570 | |||
INR level | > 1.2 | 1.3 | 1.1–1.6 | 0.003 | 1.0 | 0.8–1.3 | 0.997 |
Platelet count | < 150/nL | 1.1 | 0.9–1.3 | 0.470 | |||
Tumor number | ≥ 2 | 1.4 | 1.2–1.7 | < 0.001 | 1.3 | 1.0–1.6 | 0.027 |
Max. lesion size | > 5.0 cm | 1.4 | 1.2–1.7 | < 0.001 | 1.7 | 1.4–2.0 | < 0.001 |
BMD | < 114 HU | 1.4 | 1.2–1.7 | < 0.001 | 1.7 | 1.4–2.1 | < 0.001 |
HR, hazard ratio; CI, confidence interval; AFP, alpha fetoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BMD, bone mineral density